1. Home
  2. EVO vs SHCO Comparison

EVO vs SHCO Comparison

Compare EVO & SHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • SHCO
  • Stock Information
  • Founded
  • EVO 1993
  • SHCO 1995
  • Country
  • EVO Germany
  • SHCO United Kingdom
  • Employees
  • EVO N/A
  • SHCO N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • SHCO Hotels/Resorts
  • Sector
  • EVO Health Care
  • SHCO Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • SHCO Nasdaq
  • Market Cap
  • EVO 1.2B
  • SHCO 1.0B
  • IPO Year
  • EVO 2021
  • SHCO 2021
  • Fundamental
  • Price
  • EVO $3.73
  • SHCO $8.85
  • Analyst Decision
  • EVO Buy
  • SHCO Strong Buy
  • Analyst Count
  • EVO 2
  • SHCO 1
  • Target Price
  • EVO $5.40
  • SHCO $9.00
  • AVG Volume (30 Days)
  • EVO 41.5K
  • SHCO 777.5K
  • Earning Date
  • EVO 11-05-2025
  • SHCO 08-08-2025
  • Dividend Yield
  • EVO N/A
  • SHCO N/A
  • EPS Growth
  • EVO N/A
  • SHCO N/A
  • EPS
  • EVO N/A
  • SHCO N/A
  • Revenue
  • EVO $912,894,891.00
  • SHCO $1,251,591,000.00
  • Revenue This Year
  • EVO $0.39
  • SHCO $11.89
  • Revenue Next Year
  • EVO $9.53
  • SHCO $7.87
  • P/E Ratio
  • EVO N/A
  • SHCO N/A
  • Revenue Growth
  • EVO N/A
  • SHCO 9.00
  • 52 Week Low
  • EVO $2.84
  • SHCO $4.60
  • 52 Week High
  • EVO $5.64
  • SHCO $8.92
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.04
  • SHCO 74.43
  • Support Level
  • EVO $3.43
  • SHCO $8.81
  • Resistance Level
  • EVO $3.55
  • SHCO $8.88
  • Average True Range (ATR)
  • EVO 0.08
  • SHCO 0.03
  • MACD
  • EVO 0.05
  • SHCO -0.07
  • Stochastic Oscillator
  • EVO 90.27
  • SHCO 30.00

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.

Share on Social Networks: